Showing results (541-550 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|January 9, 2009
Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat modelDavid S Hydock, Chia-Ying Lien, Reid HaywardJournal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular functionAndrew Mykytsey, Jerry L Bauman, Mansour Razminia, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Transmyocardial revascularization: peril and potentialJordan Tasse, Rohit AroraJournal of Cardiovascular Pharmacology and Therapeutics|May 15, 2007
Short-term intra-arterial infusion of monocyte chemoattractant protein-1 results in sustained collateral artery growthRandolph W Seidler, Martin C Lenter, Brian D Guth, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 3, 2009
Modification of epinephrine-induced arrhythmias by N-acetyl-L-cysteine and vitamin ERajat Sethi, Adriana Adameova, Ken S Dhalla, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 4, 2009
The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effectsAmit N Keswani, Kelly J Peyton, William Durante, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 3, 2022
Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac SurgeryDannick Brochu, Amélie St-Arnaud, Louis-Étienne Marchand, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 10, 2023
Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old RatsRuslan B Strutynskyi, Nataliіa A Strutynska, Oksana O Piven, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 3, 2024
MARRIAGE: A Randomized Trial of Moxonidine Versus Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic ParametersPaul Valensi, Selim JambartJournal of Cardiovascular Pharmacology and Therapeutics|March 13, 2018
Opioids in Cardiovascular Disease: Therapeutic OptionsHemangi Rawal, Bhoomika M PatelPageof 129